Siontis Konstantinos C, Kara Balla Abdalla, Cha Yong-Mei, Pilgrim Thomas, Sweda Romy, Roten Laurent, Reichlin Tobias, Friedman Paul A, Windecker Stephan, Siontis George C M
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
Heart Rhythm O2. 2022 Oct 22;4(1):24-33. doi: 10.1016/j.hroo.2022.10.007. eCollection 2023 Jan.
Atrioventricular conduction abnormalities after transcatheter aortic valve implantation (TAVI) are common. The value of electrophysiological study (EPS) for risk stratification of high-grade atrioventricular block (HG-AVB) and guidance of permanent pacemaker (PPM) implantation is poorly defined.
The purpose of this study was to identify EPS parameters associated with HG-AVB and determine the value of EPS-guided PPM implantation after TAVI.
We performed a systematic review and meta-analysis of studies investigating the value of EPS parameters for risk stratification of TAVI-related HG-AVB and for guidance of PPM implantation among patients with equivocal PPM indications after TAVI.
Eighteen studies (1230 patients) were eligible. In 7 studies, EPS was performed only after TAVI, whereas in 11 studies EPS was performed both before and after TAVI. Overall PPM implantation rate for HG-AVB was 16%. AV conduction intervals prolonged after TAVI, with the AH and HV intervals showing the largest magnitude of changes. Pre-TAVI HV >70 ms and the absolute value of the post-TAVI HV interval were associated with subsequent HG-AVB and PPM implantation with odds ratios of 2.53 (95% confidence interval [CI] 1.11-5.81; = .04) and 1.10 (95% CI 1.03-1.17; = .02; per 1-ms increase), respectively. In 10 studies, PPM was also implanted due to abnormal EPS findings in patients with equivocal PPM indications post-TAVI (typically new left bundle branch block or transient HG-AVB). Among them, the rate of long-term PPM dependency was 57%.
Selective EPS testing may assist in the risk stratification of post-TAVI HG-AVB and in the guidance of PPM implantation, especially in patients with equivocal PPM indications post-TAVI.
经导管主动脉瓣植入术(TAVI)后房室传导异常很常见。电生理研究(EPS)对高度房室传导阻滞(HG-AVB)进行风险分层以及指导永久起搏器(PPM)植入的价值尚不清楚。
本研究的目的是确定与HG-AVB相关的EPS参数,并确定TAVI后EPS指导下PPM植入的价值。
我们对研究EPS参数对TAVI相关HG-AVB进行风险分层以及对TAVI后PPM植入指征不明确的患者指导PPM植入的价值的研究进行了系统评价和荟萃分析。
18项研究(1230例患者)符合条件。7项研究中,EPS仅在TAVI后进行,而11项研究中,EPS在TAVI前后均进行。HG-AVB的总体PPM植入率为16%。TAVI后房室传导间期延长,AH和HV间期变化幅度最大。TAVI前HV>70 ms以及TAVI后HV间期的绝对值与随后的HG-AVB和PPM植入相关,优势比分别为2.53(95%置信区间[CI]1.11-5.81;P = 0.04)和1.10(95%CI 1.03-1.17;P = 0.02;每增加1 ms)。在10项研究中,TAVI后PPM植入指征不明确的患者(通常为新发左束支传导阻滞或短暂HG-AVB)也因EPS结果异常而植入PPM。其中,长期PPM依赖率为57%。
选择性EPS检测可能有助于TAVI后HG-AVB的风险分层和PPM植入的指导,尤其是TAVI后PPM植入指征不明确的患者。